Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

NCT07417215 is registered in ClinicalTrials.gov with University Clinical Hospital Mostar as lead sponsor.

NCT NCT07417215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07417215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF
Lead sponsor
University Clinical Hospital Mostar
Phase
Phase 4
Overall status
Completed
Start date
January 30, 2026
Completion date
May 10, 2026
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction (hfpef), hemodialysis, sacubitril/valsartan